+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum microRNA miR-206 is decreased in hyperthyroidism and mediates thyroid hormone regulation of lipid metabolism in HepG2 human hepatoblastoma cells



Serum microRNA miR-206 is decreased in hyperthyroidism and mediates thyroid hormone regulation of lipid metabolism in HepG2 human hepatoblastoma cells



Molecular Medicine Reports 17(4): 5635-5641



The actions of thyroid hormone (TH) on lipid metabolism in the liver are associated with a number of genes involved in lipogenesis and lipid metabolism; however, the underlying mechanisms through which TH impacts on lipid metabolism remain to be elucidated. The present study aimed to investigate the effects of hyperthyroidism on the serum levels of the microRNA (miR) miR‑206 and the role of miR‑206 on TH‑regulated lipid metabolism in liver cells. Serum was obtained from 12 patients diagnosed with hyperthyroidism and 10 healthy control subjects. Human hepatoblastoma (HepG2) cells were used to study the effects of triiodothyronine (T3) and miR‑206 on lipid metabolism. Expression of miR‑206 in serum and cells was determined by reverse transcription‑quantitative polymerase chain reaction analysis. Lipid accumulation in HepG2 cells was assessed with Oil Red O staining. Suppression or overexpression of miR‑206 was performed via transfection with a miR‑206 mimic or miR‑206 inhibitor. Serum miR‑206 was significantly decreased in patients with hyperthyroidism compared with euthyroid controls. Treatment of HepG2 cells with T3 led to reduced total cholesterol (TC) and triglyceride (TG) content, accompanied by reduced miR‑206 expression. Inhibition of endogenous miR‑206 expression decreased intracellular TG and TC content in HepG2 cells. By contrast, overexpression of miR‑206 in HepG2 partially prevented the reduction in TG content induced by treatment with T3. In conclusion, serum miR‑206 expression is reduced in patients with hyperthyroidism. In addition, miR‑206 is involved in T3‑mediated regulation of lipid metabolism in HepG2 cells, indicating a role for miR‑206 in thyroid hormone‑induced disorders of lipid metabolism in the liver.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065507005

Download citation: RISBibTeXText

PMID: 29484422

DOI: 10.3892/mmr.2018.8633


Related references

Ca2+ influx mediates apoptosis induced by 4-aminopyridine, a K+ channel blocker, in HepG2 human hepatoblastoma cells. Pharmacology 60(2): 74-81, 2000

Activation of Na(+), K(+), Cl(-)-cotransport mediates intracellular Ca(2+) increase and apoptosis induced by Pinacidil in HepG2 human hepatoblastoma cells. Biochemical and Biophysical Research Communications 281(2): 511-519, 2001

Decreased parathyroid function in hyperthyroidism: interrelationships between serum parathyroid hormone, calcium-phosphorus metabolism and thyroid function. Acta Endocrinologica 84(3): 566-575, 1977

Thyroid hormone action on intermediary metabolism. Part II: Lipid metabolism in hypo- and hyperthyroidism. Klinische Wochenschrift 62(2): 49-55, 1984

Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism. Biochimica et Biophysica Acta 1861(1): 51-59, 2016

Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells. Biochemical Journal 375(Pt 2): 441-447, 2003

Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells. Journal of Clinical Endocrinology and Metabolism 82(11): 3758-3762, 1997

Uptake and metabolism of 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine by human liver-derived cells: HepG2 cells as a model for thyroid hormone handling by human liver. Journal of Clinical Endocrinology and Metabolism 81(1): 244-248, 1996

Antiarrhythmic amiodarone mediates apoptotic cell death of HepG2 hepatoblastoma cells through the mitochondrial pathway. Acta Medica Nagasakiensia 49(1-2): 13-17, 2004

Regulation of hepatic triglyceride lipase by thyroid hormone in HepG2 cells. Journal of Lipid Research 34(6): 961-970, 1993

MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. Febs Journal 276(11): 2966-2982, 2009

Upregulation of ldl receptor mediated metabolism by thyroid hormone in fibroblasts and hepg2 cells. Journal of Cell Biology 107(6 PART 3): 769A, 1988

Regulation of rabbit CYP2E1 expression in HepG2 cells by insulin and thyroid hormone. FASEB Journal 11(9): A820, 1997

Pandanus tectorius derived caffeoylquinic acids inhibit lipid accumulation in HepG2 hepatoma cells through regulation of gene expression involved in lipid metabolism. Yao Xue Xue Bao 50(3): 278-283, 2015

Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone. Molecular Pharmacology 54(4): 740-747, 1998